Disease management
It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from just 500 microlitres of blood serum.
Funded by the Queensland government, a University of Queensland project is developing a VR program for practising safe falls for the first time among patients with spinal cord injury.
Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.
A neurologist's startup has developed a foundation model, based on 60,000 hours of brain wave records, which reportedly achieved 95% accuracy in identifying epilepsy biomarkers.
The University of Kansas Health System, KU Medical Center, Children's Mercy and BAMF Health are partnering to develop a theranostics platform for adult and pediatric patients.
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
Also, Ubie is collaborating with Mayo Clinic on a new unified patient digital front door.
Emerging Technologies
Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.
Emerging Technologies
Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.
Deep GI project lead Dr Rungsun Rerknimitr reveals a three-year plan to validate and scale a deployable AI-powered diagnosis system beyond colorectal screening.